The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Interferon Lambda: Modulating Immunity in Infectious Diseases
Open accessAbstract
Interferon-λs 1-4 (IFNL1-4) modulate immunity in the context of infections and autoimmune diseases, through a complex network of induced genes. IFN-λs act by binding to the hetero-dimeric IFN-λ receptor (IFNLR), activating a STAT-phosphorylation dependent signalling cascade, and thereby inducing hundreds of IFN-stimulated genes modulating various immune functions via complex forward and feedback loops. In contrast to the IFN-α signalling cascade, three important differences have been discovered. Firstly, the IFNLR is not ubiquitously expressed; in particular, immune cells show significant variation in the expression levels and susceptibilities to IFN-λs. Secondly, the binding affinities of individual IFN-λs to the IFNLR strongly varies and are generally lower compared to IFN-α binding affinities. Finally, genetic variation in the form of a series of single nucleotide polymorphisms (SNPs) linked to genes involved in the IFN-λ signalling cascade has been described, and associated with the clinical course and treatment outcomes of hepatitis B and C virus infection. The clinical impact of the IFN-λ signalling and the SNP variations may, however, reach far beyond viral hepatitis. Recent publications show important roles for IFN-λs in a broad range of viral infections such as human T-cell leukemia type-1 virus, rotaviruses and influenza virus. Potentially IFN-λ even modulates the course of bacterial colonization and infections as shown for Staphylococcus aureus and Mycobacterium tuberculosis. Although the immunological processes involved in controlling viral and bacterial infections are highly diverse, IFN-λs may interfere at various levels: as an innate immune cytokine with direct antiviral effects; or as a modulator of the IFN-α induced signalling via the suppressor of cytokine signalling 1 (SOCS1) and the Ubiquitin specific peptidase 18 (USP18) inhibitory feedback loops. In addition, the modulation of adaptive immune functions via macrophage and dendritic cell polarization, and subsequent priming, activation, and proliferation of pathogen-specific T- and B-cells may also be important elements associated with infectious diseases outcomes. This review summarizes the emerging details of the IFN-λ immunobiology in the context of the host immune response and viral and bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419
Phagocyte partnership during the onset and resolution of inflammation
Soehnlein, O., & Lindbom, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2779 · Cited by 1,054
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
Lazear, H. M., Daniels, B. P., Pinto, A. K., Huang, A. C., Vick, S. C., Doyle, S. E., Gale, M., Klein, R. S., & Diamond, M. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4304 · Cited by 234
To B or not to B: B cells and the Th2-type immune response to helminths
Harris, N., & Gause, W. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.005 · Cited by 166
Planet, P. J., Parker, D., Cohen, T. S., Smith, H., Leon, J. D., Ryan, C., Hammer, T. J., Fierer, N., Chen, E. I., & Prince, A. S. (2016) · mBio · doi:10.1128/mbio.01939-15 · Cited by 113
Cited by
Katsura, H., Sontake, V., Tata, A., Kobayashi, Y., Edwards, C. E., Heaton, B. E., Konkimalla, A., Asakura, T., Mikami, Y., Fritch, E. J., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.005 · Cited by 416
Interferon-λ orchestrates innate and adaptive mucosal immune responses
Ye, L., Schnepf, D., & Staeheli, P. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0182-z · Cited by 266
Yu, J., Yan, J., Guo, Q., Chi, Z., Tang, B., Zheng, B., Yu, J., Yin, T., Cheng, Z., Wu, X., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0475 · Cited by 100
Duque-Correa, M. A., Karp, N. A., McCarthy, C., Forman, S., Goulding, D., Sankaranarayanan, G., Jenkins, T. P., Reid, A. J., Cambridge, E. L., Ballesteros Reviriego, C., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007265 · Cited by 35
Arora, P., Moll, J. M., Andersen, D., Workman, C. T., Williams, A. R., Kristiansen, K., & Brix, S. (2020) · Immunology · doi:10.1111/imm.13151 · Cited by 23
Metadata
- Authors
- Syedbasha, M., & Egli, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-02-28
- Volume
- 8
- Pages
- 119-119
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2593038077
- Cited by
- 160
- References
- 8
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon Lambda: Modulating Immunity in Infectious Diseases. https://app.cochat.ai/papers/10.3389/fimmu.2017.00119
- The paper
- Syedbasha, M., & Egli, A. (2017). Interferon Lambda: Modulating Immunity in Infectious Diseases. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.00119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.